Dr. David Wojciechowski, DO
Claim this profileUniversity of Texas Southwestern Medical Center
Studies Immunosuppression
Studies Determination of Death
7 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials David Wojciechowski, DO is currently running
Belatacept
for Immunosuppression in Kidney Transplant Recipients
The purpose of the study is to identify kidney transplant patients that can be transitioned from multi-drug immunosuppression therapy to Belatacept monotherapy, using cell free DNA and gene expression as markers of immune quiescence. The primary objective will be to determine if donor derived-cell free DNA (AlloSure) can be utilized to facilitate Belatacept monotherapy, and to determine if Belatacept is safe and effective as immunosuppression in kidney transplant recipients. The secondary objective is to determine the utility of AlloMap as a predictor of immune quiescence and tolerance of immunosuppressive de-escalation to Belatacept monotherapy, and to evaluate the performance of iBox in predicting adverse outcomes in patients transitioned to Belatacept monotherapy
Recruiting3 awards Phase 4
Iptacopan
for Atypical Hemolytic Uremic Syndrome
This trial is testing iptacopan, a new medication, in adults with a rare disease called aHUS. The drug aims to calm an overactive part of their immune system to improve their health.
Recruiting2 awards Phase 32 criteria
More about David Wojciechowski, DO
Clinical Trial Related3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments David Wojciechowski, DO has experience with
- Belatacept
- HIV D+/R+
- AntiBKV
- Iptacopan
- HIVD+/R+
Breakdown of trials David Wojciechowski, DO has run
Immunosuppression
Determination of Death
HIV (Human Immunodeficiency Virus)
Epstein-Barr Virus
BK Virus Infection
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Wojciechowski, DO specialize in?
David Wojciechowski, DO focuses on Immunosuppression and Determination of Death. In particular, much of their work with Immunosuppression has involved treating patients, or patients who are undergoing treatment.
Is David Wojciechowski, DO currently recruiting for clinical trials?
Yes, David Wojciechowski, DO is currently recruiting for 2 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that David Wojciechowski, DO has studied deeply?
Yes, David Wojciechowski, DO has studied treatments such as Belatacept, HIV D+/R+, AntiBKV.
What is the best way to schedule an appointment with David Wojciechowski, DO?
Apply for one of the trials that David Wojciechowski, DO is conducting.
What is the office address of David Wojciechowski, DO?
The office of David Wojciechowski, DO is located at: University of Texas Southwestern Medical Center, Dallas, Texas 75390 United States. This is the address for their practice at the University of Texas Southwestern Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.